Identify the comparable recommendations from ASPEN’s 2016 critical illness guidelines.For each of the questions posed in the 2021 guidelines (#1-5b), compare and contrast the new guideline with the comparable guideline from 2016.Identify how each guideline has changed (or stayed the same) and what this means for practice. Q1. In adult critcally ill patients, does provision of higher vs lower energy intake impact clinical outcomes?Q2. In adult critically ill patients, does provision of higher as compared with lower protein intake impact clinical outcomes?Q3. In adult critcally ill patients who are candidates for EN, does similar energy intake by PN vs EN as the primary feeding modality in the first week of critical illness impact clinical outcomes?Q4. In adult critically ill patients recieving early EN, does provision of SPN to meet energy targets vs no SPN during the first week of critical illness impact clinical outcomes?Q5a. In adult critically ill patients recieving PN, does provision of mixed-oil ILES (ie: medium chain triglycerides, olive oil, FO, mixtures of oils), as compared with 100% SO ILE, impact clinical outcomes?Q5b. In adult critically ill patients reciving PN, does provision of FO-containing ILE, as copmared with non-FO containing ILE, impact clinical outcomes? Please provide the letter/number combination for the applicable 2016 recommendation.
Identify the comparable recommendations from ASPEN’s 2016 critical illness guidelines.
For each of the questions posed in the 2021 guidelines (#1-5b), compare and contrast the new guideline with the comparable guideline from 2016.
Identify how each guideline has changed (or stayed the same) and what this means for practice.
Q1. In adult critcally ill patients, does provision of higher vs lower energy intake impact clinical outcomes?
Q2. In adult critically ill patients, does provision of higher as compared with lower protein intake impact clinical outcomes?
Q3. In adult critcally ill patients who are candidates for EN, does similar energy intake by PN vs EN as the primary feeding modality in the first week of critical illness impact clinical outcomes?
Q4. In adult critically ill patients recieving early EN, does provision of SPN to meet energy targets vs no SPN during the first week of critical illness impact clinical outcomes?
Q5a. In adult critically ill patients recieving PN, does provision of mixed-oil ILES (ie: medium chain triglycerides, olive oil, FO, mixtures of oils), as compared with 100% SO ILE, impact clinical outcomes?
Q5b. In adult critically ill patients reciving PN, does provision of FO-containing ILE, as copmared with non-FO containing ILE, impact clinical outcomes?
Please provide the letter/number combination for the applicable 2016 recommendation.
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
